Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
pipeline
Biotech
Pyxis whittles pipeline down to one clinical asset
Pyxis Oncology has axed one of two clinical candidates to streamline resources to its antibody-drug conjugate.
Gabrielle Masson
Dec 20, 2024 6:15am
Merck discontinues development of 2 late-stage cancer assets
Dec 16, 2024 5:39pm
iTeos drops one of 3 clinical assets from pipeline
Dec 12, 2024 3:10pm
Novartis 'took data to heart' before slimming pipeline by 40%
Nov 21, 2024 5:07am
CSL Behring shuts down California cell and gene therapy R&D site
Nov 18, 2024 8:35am
Omega halts sole clinical-stage asset to focus on 3 programs
Nov 15, 2024 5:33am
